Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Antibacterial therapy in patients with malignancies

    Patients with malignant disease may be predisposed to bacterial infections because of neoplastic disruption of normal tissue barriers, exogenous immunosuppressive therapy (drugs with or without radiation), and...

    Kenneth H. Mayer, Steven M. Opal in Cancer and Metastasis Reviews (1987)

  2. No Access

    Article

    The Microbial Consequences of Antimediator Therapy for Sepsis

    Steven M. Opal, Alan S. Cross in Sepsis (1997)

  3. No Access

    Article

    Immunocompromised Animals in Sepsis Research

    Steven M. Opal, Alan S. Cross in Sepsis (1998)

  4. No Access

    Chapter

    Endotoxin scavengers as a therapeutic strategy for sepsis

    Bacterial endotoxin remains an important therapeutic target for the treatment of serious infections from Gram-negative bacterial pathogens. Despite recent failures in past clinical trials with novel anti-endot...

    Steven M. Opal in Cytokines in Severe Sepsis and Septic Shock (1999)

  5. No Access

    Article

    New Potential Therapeutic Modalities: Antithrombin III

    The role of the disordered coagulation in the pathogenesis of the microcirculatory failure that frequently accompanies sepsis has been clearly established in a multitude of preclinical animal systems. There is...

    Steven M. Opal, Lambert G. Thijs in Sepsis (1999)

  6. Article

    Immunoprophylaxis Against Bacterial Sepsis

    Sepsis can be viewed as toxigenic illness resulting from the release of excess quantities of microbial-derived inflammatory mediators into the systemic circulation. Principal among these microbial mediators is...

    Steven M. Opal, Alan S. Cross, Apurba K. Bhattacharjee, Kumar Visvanathan in Sepsis (1999)

  7. No Access

    Chapter

    Interleukin-11: Potential Therapeutic Activity in Systemic Inflammatory States

    Interleukin-11 IL-11) is a multifunctional, immunoregulatory cytokine with several unique attributes that has therapeutic potential in a number of systemic inflammatory states. Like many other pleiotropic cyto...

    Steven M. Opal, James C. Keith Jr. in Multiple Organ Failure (2000)

  8. No Access

    Article

    The Genomic Era and 21st Century Medicine: Its Potential Impact in Sepsis Research

    Steven M. Opal in Sepsis (2001)

  9. No Access

    Chapter

    Vaccines Against Bacterial Endotoxins

    The use of vaccines that induce antibodies to either highly conserved epitopes in the LPS core or to serotype-specific antigens (O-polysaccharide or CPS) remains a viable strategy for the prevention and/or tre...

    Apurba K. Bhattacharjee, Alan S. Cross, Steven M. Opal in The Sepsis Text (2002)

  10. No Access

    Chapter

    Immunopathogenesis of Gram-Negative Shock

    It has become evident that Gram-negative bacterial pathogens have evolved an elaborate array of virulence factors that contribute to the immunopathogenesis of systemic infection and septic shock. Microorganism...

    Steven M. Opal, Christian E. Hubert in The Sepsis Text (2002)

  11. Article

    Bench-to-bedside review: Toll-like receptors and their role in septic shock

    The Toll-like receptors (TLRs) are essential transmembrane signaling receptors of the innate immune system that alert the host to the presence of a microbial invader. The recent discovery of the TLRs has rapid...

    Steven M Opal, Christian E Huber in Critical Care (2002)

  12. Article

    Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]

    Treatment of sepsis is aimed at increasing both the duration and quality of survival. A long-term focus on quality of life (QoL) in clinical trial evaluations of sepsis care should be a priority.

    Dale Rublee, Steven M Opal, Wolfgang Schramm, Heinz-Otto Keinecke in Critical Care (2002)

  13. Article

    Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis

    The innate immune response system is designed to alert the host rapidly to the presence of an invasive microbial pathogen that has breached the integument of multicellular eukaryotic organisms. Microbial invas...

    Steven M Opal, Charles T Esmon in Critical Care (2002)

  14. No Access

    Article

    2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

    In 1991, the American College of Chest Physicians (ACCP) and the Society of Critical Care Medicine (SCCM) convened a "Consensus Conference," the goals of which were to "provide a conceptual and a practical fra...

    Mitchell M. Levy, Mitchell P. Fink, John C. Marshall in Intensive Care Medicine (2003)

  15. No Access

    Article

    Coagulation in sepsis

    Coagulation abnormalities, ranging from a simple fall in platelet count to full-blown disseminated intravascular coagulation, are a common occurrence in critically ill patients and have been associated with i...

    André Amaral, Steven M. Opal, Jean-Louis Vincent in Intensive Care Medicine (2004)

  16. Article

    Role of Toll-Like Receptors in Infection and Immunity

    The remarkable discovery of the Toll-like receptors (TLRs) over the past 5 years has opened up an entirely new era in the understanding of the molecular events that initiate the inflammatory response. These ty...

    Dr Patricia Cristofaro, Steven M. Opal in Drugs (2006)

  17. Article

    Coagulation abnormalities in critically ill patients

    Many critically ill patients develop hemostatic abnormalities, ranging from isolated thrombocytopenia or prolonged global clotting tests to complex defects, such as disseminated intravascular coagulation. Ther...

    Marcel Levi, Steven M Opal in Critical Care (2006)

  18. Article

    Open Access

    Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection

    The receptor for advanced glycation end products (RAGE), a multi-ligand member of the immunoglobulin superfamily, contributes to acute and chronic disease processes, including sepsis.

    Emily C Lutterloh, Steven M Opal, Debra D Pittman, James C Keith Jr in Critical Care (2007)

  19. Article

    Bench-to-bedside review: Quorum sensing and the role of cell-to-cell communication during invasive bacterial infection

    Bacteria communicate extensively with each other and employ a communal approach to facilitate survival in hostile environments. A hierarchy of cell-to-cell signaling pathways regulates bacterial growth, metabo...

    Shadaba Asad, Steven M Opal in Critical Care (2008)

  20. Article

    Open Access

    A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia

    The purpose of this analysis was to determine the potential efficacy of recombinant human tissue factor pathway inhibitor (tifacogin) in a subpopulation of patients with community-acquired pneumonia (CAP) from...

    Pierre-François Laterre, Steven M Opal, Edward Abraham, Steven P LaRosa in Critical Care (2009)

previous disabled Page of 2